Cbd

CBD (cannabidiol) represents a major cannabinoid family distinguished by elevated cannabidiol content relative to THC. Lineage records frequently report CBD-dominant cultivars emerging from crosses involving Charlottes Web, Cannatonic, and Remedy parents, though breeding programs worldwide have developed independent CBD-rich lines. The CBD family encompasses both high-CBD/low-THC and balanced CBD:THC ratios, created through selective breeding for CBDA synthase enzyme expression. Breeders working in this category often document cannabinoid profiles via third-party testing rather than phenotypic traits alone, since CBD expression requires biochemical analysis. This family has become foundational in breeding programs focused on cannabinoid diversity and research genetics.

CBD genetics serve as crucial parent material for breeders developing cannabinoid-varied cultivars and for creating F1 hybrids with predictable CBD/THC ratios. Stabilizing CBD expression across generations requires understanding the genetic markers controlling cannabinoid synthase pathways and maintaining consistent testing protocols across seed populations.